{"transactions":[{"id":703093,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-07-27T20:08:29.000Z","date":"2026-07-23","kind":"sale","planned":false,"acquired":false,"shares":7429,"price":2.97,"value":22064.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award.  This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":704106,"source":{"system":"sec-edgar","filing":"0000905148-26-003354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514826003354/form4.xml","form_type":"4"}},{"id":800297,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-04-27T20:28:53.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":7470,"price":5.2371,"value":39121.137,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2314 to $5.2413, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":711535,"source":{"system":"sec-edgar","filing":"0000905148-26-001867","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514826001867/form4.xml","form_type":"4"}},{"id":931349,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-01-27T00:51:09.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":719005,"source":{"system":"sec-edgar","filing":"0000905148-26-000359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514826000359/form4.xml","form_type":"4"}},{"id":1013938,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-10-24T20:16:14.000Z","date":"2025-10-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":23795,"price":1.95,"value":46400.25,"ownership":{"direct":true},"balance_after":319005,"source":{"system":"sec-edgar","filing":"0000905148-25-003670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514825003670/form4.xml","form_type":"4"}},{"id":1353017,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-11-25T21:18:07.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9834,"value":9834.0,"ownership":{"direct":true},"balance_after":342800,"source":{"system":"sec-edgar","filing":"0000905148-24-003268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514824003268/form4.xml","form_type":"4"}},{"id":1369389,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-11-12T21:35:35.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":332800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third, and fourth anniversary of October 22, 2024, subject to the Reporting Person's continuing service."}],"balance_after":332800,"source":{"system":"sec-edgar","filing":"0000905148-24-003015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514824003015/form4.xml","form_type":"4"}},{"id":1472346,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:15:21.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2025, subject to the Reporting Person's continuous service as of such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.15,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-24-017826","document":"form4-06212024_040616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000141588924017826/form4-06212024_040616.xml","form_type":"4"}},{"id":1516245,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T21:28:42.000Z","date":"2024-05-15","kind":"purchase","planned":false,"acquired":true,"shares":7813,"price":1.31,"value":10235.03,"ownership":{"direct":true},"balance_after":17957,"source":{"system":"sec-edgar","filing":"0001415889-24-013248","document":"form4-05152024_090534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000141588924013248/form4-05152024_090534.xml","form_type":"4"}},{"id":1845528,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:36:51.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2024, subject to the Reporting Person's continuous service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.31,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-039416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000120919123039416/doc4.xml","form_type":"4"}},{"id":2222245,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:27:18.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023."}],"balance_after":30000,"derivative":{"exercise_price":1.62,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-039237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000120919122039237/doc4.xml","form_type":"4"}},{"id":2350880,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T22:09:55.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable in 36 equal monthly installments beginning on April 2, 2022, subject to the Reporting Person's continuous service as of such vesting dates."}],"balance_after":30000,"derivative":{"exercise_price":1.49,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-016390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000120919122016390/doc4.xml","form_type":"4"}}]}